Explore the Knowledge Graph

Targets

Every human protein, and what every drug does to it

Coverage

  • Every protein a drug acts on. The full reviewed human proteome, 20,500+ proteins, plus 2,100+ proteins from 575 other organisms — the bacterial, viral, and parasite targets of anti-infectives.
  • Direction on every drug relationship. Agonist, antagonist, inhibitor, inducer, substrate, recorded per relationship.
  • Binding strength where measured. Ki, Kd, IC50, and EC50 in nanomolar, each with the measurement and publication count behind it.
  • Targets, enzymes, transporters, and channels. 5,400+ enzymes, 950+ transporters, 850+ GPCRs, and 590+ kinases.

Where it connects

Target record Glucagon-like peptide 1 receptor P43220 protein · G protein coupled receptor
Drugs Every approved, clinical-stage, and preclinical asset acting on it
nameSemaglutide drugbank_idDB13928 action_typeagonist pharmacological_actionyes approval_statusapproved, investigational modalityPeptides +91 more drugs
Diseases The indications those assets are aimed at
condition_titleType 2 Diabetes condition_drugbank_idDBCOND0030616 ttd_strength_of_evidencePhase 3; Approved opentargets_strength_of_evidencenull combined_score1.4994 +492 more conditions
Clinical trials Who's testing it, and at what phase
NCT07241390 NCT07551492 NCT07037459 NCT07165028 +2,769 more

NCT07241390

statusrecruiting phase3 enrollment7140 start_date2025-12-01
Companies Who owns those programs today

Via a registered trial

drugSemaglutide sponsor.title (as filed)Novo Nordisk A/S sponsor_company.name (resolved)Novo Nordisk across 275 trials

Via a preclinical program

programDBPRG00174092 raw_phasepreclinical company.name (resolved)Structure Therapeutics +259 more programs

Zoom in

GLP1R (P43220) · binding strength by measure
drugdrug_drugbank_idpharmacological_actionec50ic50kikdmeasurement_count
SemaglutideDB13928yes0.0191.97null4416
PF-06882961DB16043yes13.0null1702.1617
OrforglipronDB18964unknown26.8nullnullnull2
LotiglipronDB21631unknown4.04nullnullnull2
GLP1R and its secretin-family neighbours
gene_nameuniprotkb_accessionprotein_cliquepfamsresiduesdrugs
GLP1RP43220G Protein Coupled Receptor7tm_2, HRM46392
GCGRP47871G Protein Coupled Receptor7tm_2, HRM47729
GIPRP48546G Protein Coupled Receptor7tm_2, HRM46626
ADCYAP1R1P41586G Protein Coupled Receptor7tm_2, HRM4680
Pathways GLP1R takes part in
pathwaypathway_drugbank_idsourcecategory
Glucagon-like Peptide-1 (GLP1) regulates insulin secretionDBPW00164797REACTOMEMetabolism
Incretins - Insulin release PathwayDBPW00051695SMPDBPhysiological
Class B/2 (Secretin family receptors)DBPW00164075REACTOMESignal Transduction
G alpha (s) signalling eventsDBPW00164735REACTOMESignal Transduction
Integration of energy metabolismDBPW00164965REACTOMEMetabolism

+8 more pathways

Enzymes acting on GLP1R drugs
drugdrug_drugbank_idenzymebiodb_idsubstrateinhibitor
SemaglutideDB13928Dipeptidyl peptidase 4BE000085410
SemaglutideDB13928Lipoprotein lipaseBE000023901
LiraglutideDB06655NeprilysinBE000026610
ExenatideDB01276Dipeptidyl peptidase 4BE000085410
OrforglipronDB18964Cytochrome P450 3A4BE000263810
OrforglipronDB18964Cytochrome P450 2J2BE000368310

+3 more enzymes

Transporters and carriers on GLP1R drugs
drugdrug_drugbank_idproteinbiodb_idtypesubstrate
OrforglipronDB18964Solute carrier organic anion transporter family member 1B1BE0001004TransporterBond1
OrforglipronDB18964ATP-dependent translocase ABCB1BE0001032TransporterBond1
OrforglipronDB18964Solute carrier organic anion transporter family member 1B3BE0003659TransporterBond1
SemaglutideDB13928AlbuminBE0000530CarrierBond1
LiraglutideDB06655AlbuminBE0000530CarrierBond0
TirzepatideDB15171AlbuminBE0000530CarrierBond0

+1 more carrier relationship

Where four target classes sit in the cell
gene_namecellular_locationtransmembrane_regionssignal_regionslocus
GLP1RCell membrane7 spans, 140–4041–236p21.2
CYP3A4Endoplasmic reticulum membrane1 span, 2–22—7q22.1
ABCB1Cell membrane12 spans, 45–977—7q21.12
ALBSecreted—1–184q13.3

Questions it answers

  • What else has been tried against this target, and what happened to it? Target diligence
  • Who's working on this target before anyone has registered a trial? Target diligence
  • Which validated targets could a different modality improve on? Modality-fit target discovery

All figures pulled as of November 2026.

Get answers you can trust, every time.